HEART PROTECTION AGAINST ISCHEMIC LESIONS: THE ROLE OF STRESS-LIMITING SYSTEMS AND STABILIZING MYOCARDIAL STRUCTURE

QR Code

HEART PROTECTION AGAINST ISCHEMIC LESIONS: THE ROLE OF STRESS-LIMITING SYSTEMS AND STABILIZING MYOCARDIAL STRUCTURE

Heart protection against ischemic lesions: the role of stress-limiting systems and stabilizing myocardial structure.

Saved in:

Bibliographic Details
Main Author:	F. Z. Meerson
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2001-10-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2058
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PRECONDITIONING AS PROTECTION AGAINST ISCHEMIC MYOCARDIAL INJURY
by: M. G. Shurygin, et al.
Published: (2013-04-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Myocardial Perfusion Scintigraphy in Ischemic Heart Disease
by: Sonia María Sánchez Valcarcel, et al.
Published: (2021-09-01)

Myocardial Infarction And Ischemic Heart Disease In Patients With Acute Ischemic Stroke
by: Daniela Arabadzhieva, et al.
Published: (2015-06-01)

The role of NO in signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury
by: L. M. Danilenko, et al.
Published: (2018-02-01)

RETRACTED ARTICLE: Protective role of arachidonic acid against diabetic myocardial ischemic injury: a translational study of pigs, rats, and humans
by: Yunhui Lv, et al.
Published: (2024-02-01)

Retraction Note: Protective role of arachidonic acid against diabetic myocardial ischemic injury: a translational study of pigs, rats, and humans
by: Yunhui Lv, et al.
Published: (2025-06-01)

Differential diagnosis of ischemic and non-ischemic myocardial lesion in a patient with COVID-19: a case report
by: S. K. Kononov, et al.
Published: (2023-08-01)

Diagnostic modalities for ischemic heart disease: evaluating the role of stress echocardiography, cardiac CT, and myocardial perfusion scintigraphy in guiding coronary angiography
by: Marco Fabio Costantino, et al.
Published: (2025-01-01)

STRUCTURAL FEATURES OF ADAPTIVE HEART PROTECTION IN ACUTE MYOCARDIAL ISCHEMIA AND INFARCTION
by: M. E. Yevsevyeva
Published: (2001-06-01)

EFFICACY OF MYOCARDIAL REVASCULARIZATION IN POTENTIAL RECIPIENTS OF HEART WITH THE CHRONIC ISCHEMIC HEART FAILURE
by: S. V. Gautier, et al.
Published: (2018-04-01)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-09-01)

The role of cardiomyocyte apoptosis in mechanisms of ischemic myocardial remodeling
by: A. P. Khlapov, et al.
Published: (2008-09-01)

Gastroprotective and Immuno-supportive Role of Alcea kurdica against Stress Induced Lesion in Japanese Quails
by: Ahmed Aj. Jabbar
Published: (2022-08-01)

Measurement of Myocardial Contractility in the Ischemic Heart – A Disease Immanent Uncertainty
by: Broscheit, Jens
Published: (2012)

EFFICIENCY OF ENDOVASCULAR MYOCARDIAL REVASCULARIZATION AS A «BRIDGE» TO HEART TRANSPLANTATION IN PATIENTS WITH ISCHEMIC HEART FAILURE
by: A. B. Mironkov, et al.
Published: (2017-01-01)

THE INFLUENCE OF ADHERENCE TO TREATMENT ON MYOCARDIAL DYSFUNCTION IN ELDERLY AND SENILE PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
by: Iu. V. Nikishchenkova, et al.
Published: (2018-02-01)

CARDIOCYTOPROTECTORS' ROLE IN THE MANAGEMENT OF ISCHEMIC CHRONIC HEART FAILURE
by: V. P. Mikhin, et al.
Published: (2009-02-01)

INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS
by: Zh. M. Sizova
Published: (2015-09-01)

ENDOTHELIAL DYSFUNCTION AND “OXIDATIVE STRESS” BY THE NONNSTABLE COURSE OF ISCHEMIC HEART DISEASE
by: A. E. Kratnov, et al.
Published: (2014-07-01)

NEUROPROTECTIVE ROLE OF BASIC FIBROBLAST GROWTH FACTOR IN ISCHEMIC BRAIN LESION: A REVIEW
by: I. V. Ostrova, et al.
Published: (2016-01-01)

LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: A. S. Kerimkulova, et al.
Published: (2016-01-01)

TREATMENT OF STABILE ISCHEMIC HEART DISEASE: IS CORONARY STENTING SUPERIOR OVER DRUG THERAPY?
by: Sergei G. Kanorskii, et al.
Published: (2019-03-01)

ROLE OF SUSTAINED SYMPATHETIC OVERACTIVATION IN THE DEVELOPMENT OF STRUCTURAL AND FUNCTIONAL MYOCARDIAL CHANGES IN HEART FAILURE
by: O. E. OSADCHII
Published: (2018-02-01)

TOWARD THE QUESTION OF ISCHEMIC MYOCARDIAL DYSFUNCTION
by: V. V. Kalyuzhin, et al.
Published: (2014-12-01)

INFLUENCE OF TORASEMIDE ON ELECTRICAL INSTABILITY OF THE HEART IN PATIENTS WITH ISCHEMIC MITRAL REGURGITATION POST MYOCARDIAL INFARCTION
by: I. B. Ibragimova, et al.
Published: (2018-04-01)

MYOCARDIAL PERFUSION ASSESSMENT IN FORECASTING EFFECT OF CORONARY ANGIOPLASTY IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE
by: A. B. Mironkov, et al.
Published: (2015-04-01)

Myocardial fibroblast activation imaging in prediction of cardiac functional improvement of non-ischemic heart failure
by: Yao Su, et al.
Published: (2025-10-01)

Prognostic value of no-reflow phenomenon in myocardial infarction: the role of the severity of ischemic damage
by: A. A. Frolov, et al.
Published: (2025-01-01)

DIFFERENTIAL DIAGNOSTICS OF ELECTROCARDIOGRAM CHANGES IN ISCHEMIC HEART DISEASE AND SPORTS STRESS INFLUENCES
by: V. I. Pavlov
Published: (2016-06-01)

VALUE OF STRESS ECHOCARDIOGRAPHY IN DIAGNOSIS OF VIABLE MYOCARDIUM IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: D. N. Perutskiy, et al.
Published: (2016-01-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

A protective role of resveratrol against the effects of immobilization stress in corpora lutea of mice in early pregnancy
by: Saif ULLAH, et al.
Published: (2020-07-01)

Soil Bacteria Support and Protect Plants Against Abiotic Stresses
by: Carmen, Bianco, et al.
Published: (2011)

LONG-TERM EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION AT THE BACKGROUND OF MULTIPLE-VESSEL LESION CORONARY ATHEROSCLEROSIS
by: M. N. Sin’kova, et al.
Published: (2014-12-01)

Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin
by: A. N. Zakirova, et al.
Published: (2022-11-01)

Transforming Growth Factor β1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Genesis
by: N. E. Zakirova, et al.
Published: (2021-03-01)

TExtravasal myocardial revascularization in complex treatment of patients with ischemic heart disease: historical background and modern condition
by: G. G. Borshev
Published: (2015-06-01)

Piperine protects against cerebral ischemic injury by regulating the Caspase-1-mediated pyroptosis pathway
by: Jiayuan Lu, et al.
Published: (2025-07-01)

ANALYSIS OF LONG TERM RESULTS OF MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE WITH A HIGH LEVEL OF TREATMENT ADHERENCE
by: N. Yu. Sokolova, et al.
Published: (2017-08-01)